Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer

Clinical trial NCT06926179 · RECRUITING

Trial details

NCT number: NCT06926179
Sponsor: Peking University Cancer Hospital & Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer (NSCLC)Neoadjuvant Immunotherapy Radiotherapy Lung Surgery

Start date: 2024-12-01
Primary completion: 2026-03-31
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.